Abstract: The system for providing computer guided ablation of tissue of a patient includes an imaging device, an ablative surgical computer system, and a set of surgical devices. The imaging device receives imaging data from a treatment region of a patient, processes the imaging data and provides imaging output data and imaging signals. The imaging output data is available to an operator. The ablative surgical computer system includes a guidance module for processing the imaging signals and providing a treatment guidance plan to the operator; and, a treatment module for acquiring and processing surgical device output data, for optimally controlling treatment parameters and providing feedback information to the operator based on the treatment guidance plan.
Type:
Grant
Filed:
November 3, 2003
Date of Patent:
April 22, 2008
Assignee:
Endocare, Inc.
Inventors:
Sanford D. Damasco, Thach Duong, Jawahar M. Ali, David J. Battles, Paul W. Mikus, Jay J. Eum
Abstract: A 3D projection reconstruction pulse sequence is employed during a CEMRA dynamic study to acquire a time course series of k-space data sets. Signals from non-vascular voxels are suppressed by reconstructing a corresponding series of low resolution images using the centers of the acquired k-space data sets, and measuring the degree to which the signal behavior of voxels therein differ from a model of unwanted signal. Signals from voxels which do not differ from the model are suppressed and the resulting filtered low resolution images are transformed back to k-space and combined with the originally acquired peripheral k-space data to form complete, filtered k-space data sets from which images may be reconstructed.
Abstract: Apparatus and methods are provided for the imaging of structures in deep tissue within biological specimens, using spectral imaging to provide highly sensitive detection. By acquiring data that provides a plurality of images of the sample with different spectral weightings, and subsequent spectral analysis, light emission from a target compound is separated from autofluorescence in the sample. With the autofluorescence reduced or eliminated, an improved measurement of the target compound is obtained.
Type:
Grant
Filed:
September 23, 2003
Date of Patent:
January 22, 2008
Assignee:
Cambridge Research and Instrumentation, Inc.